Xiaochen Shu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Transforming Growth Factor

Muscle Invasive Bladder Cancer

Long Noncoding Rna

Top Venues

Journal of oncology

European journal of clinical investigation

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Haifeng Zhang, Junlan Qiu, Fang Meng, Xiaochen Shu
Insight into the causality between basal metabolic rate and endometrial and ovarian cancers: Analysis utilizing systematic Mendelian randomization and genetic association data from over 331,000 UK biobank participants. European journal of clinical investigation (2023)
Junlan Qiu, Haifeng Zhang, Dongkui Xu, Lin Li, Lingkai Xu, Yiqing Jiang, Tao Wen, Shun Lu, Fang Meng, Lin Feng, Xiaochen Shu
Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis. Journal of oncology 2022 (2022)
Lingkai Xu, Lin Li, Dongkui Xu, Junlan Qiu, Qingting Feng, Tao Wen, Shun Lu, Fang Meng, Xiaochen Shu
Hormone replacement therapy in relation to the risk of colorectal cancer in women by BMI: a multicentre study with propensity score matching. International journal of clinical oncology 27 (4) (2022)
Yueyi Feng, Qingting Feng, Lingkai Xu, Yiqing Jiang, Fang Meng, Xiaochen Shu
A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma. Journal of oncology 2019 (2019)